CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

CUSIP: 71902K105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
5,169,697
Total 13F shares
15,151,664
Share change
+565,101
Total reported value
$152,959,000
Price per share
$10.09
Number of holders
65
Value change
+$5,823,455
Number of buys
34
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 71902K105?
CUSIP 71902K105 identifies CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q3 2022

As of 30 Sep 2022, CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,151,664 shares. The largest 10 holders included Saba Capital Management, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, Periscope Capital Inc., D. E. Shaw & Co., Inc., HSBC HOLDINGS PLC, JANUS HENDERSON GROUP PLC, Polar Asset Management Partners Inc., FIR TREE CAPITAL MANAGEMENT LP, and HGC Investment Management Inc.. This page lists 65 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.